IBEC and Vitala, a spin-off founded by IBEC researchers, are set to participate in three public-private partnership projects, with a combined investment nearing €4 million. These initiatives, backed by the Spanish Ministry of Science and Innovation and the State Research Agency, aim to advance remote health monitoring, create an oral drug for Inflammatory Bowel Disease, and enhance 13C magnetic resonance imaging for therapeutic research. Leveraging cutting-edge technological approaches, these endeavors aspire to make a positive impact on the fields of medicine and biomedical research.
A recent IBEC study has described how cells contact guidance is not only topography-dependent but also affected by the stiffness of the environment. The work highlights the importance of considering … Read more
Researchers at IBEC have developed a 3D model of the human intestine that simulates the characteristics of the intestinal mucosa and its reliefs. These mini-intestines will make it possible to … Read more
Investigadores del Instituto de Bioingeniería de Cataluña desarrollan un modelo de intestino humano en 3D que simula las características de la mucosa intestinal y su relieve. Este mini-intestino ha permitido recrear … Read more
Data límit: 20/06/2022
Biomimetic systems for cell engineering Group is looking for a for a Research Assistant. The contract will be within the framework of an ERC Proof-of-concept project (GUT3DPLATE), whose objective is the fabrication and validation of ready-to-use hydrogel in vitro models of tissue barriers using 3D bioprinting.